written by reader Help Me Identify Alzheimer’s MicroCaps Winners

By bigger, February 4, 2017

I’m not sure what happened to the the original text, therefore here comes my second attempt..

I recently made two investments in tiny Alzheimer’s biotech companies: Promis Neurosciences ($PMN.TO) and Neurotrope ($NTRP $NTRPD). I’m interested in making more investment in the real estate located at the intersection of Toxic Oligomers (prions)/Tau/Synapses Regeneration. I explain the rational in a post titled Help Me Identify Alzheimer’s Microcaps Winners:

http://biggercapital.squarespace.com/biggercapital-investment/2016/10/15/help-me-identify-alzheimers-microcap-winners.html

I do believe Neurotrope Phase 2b topline Readout due in April and Promis Neurosciences cohort study results due in Q2 ( http://biggercapital.squarespace.com/biggercapital-investment/2017/1/9/an-alzheimers-watershed-event-on-our-doorstep.html) could turn the Alzheimer’s world on its head.

If you know any tiny companies with great MOAs operating on that real estate, please let me know. There is a Swedish biotech company I’m following closely: Alzinova. I will be meeting the CEO at the AAIC in London this summer. If you attend, let’s meetup. If you know anything about this company please let me know. I don’t have an investment.

I usually invest directly into companies. I’m also a cheap bastard!

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.

guest

12345

This site uses Akismet to reduce spam. Learn how your comment data is processed.

5 Comments
Inline Feedbacks
View all comments
SoGiAm
Irregular
👍 11543